Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 501 - 510 of 694 studies

Neurological

Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults with Angelman Syndrome (ION582-CS2 (REVEAL))

Oral and Gastrointestinal

A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy, safety, and tolerability of SAR444336 in participants with microscopic colitis in clinical remission with budesonide. (ACT18053)

Neurological

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Turning6 - A Clinical and Neurodevelopmental follow up of EPIPEG participants at 60 months (Turning6)

Cancer and neoplasms

A Phase 3, randomized, open-label study of belantamab mafodotin administered in combination with lenalidomide and dexamethasone (BRd) versus daratumumab, lenalidomide, and dexamethasone (DRd) in participants with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation (TI-NDMM)-DREAMM-10 (DREAMM-10)

Cardiovascular

A Phase 2A, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986435/MYK-224 in Participants with Heart Failure with Heart Failure with Preserved Ejection Fraction (HFpEF) (CV029-1001 (AURORA))

Predicting the Pain Outcome of Surgery for Endometriosis (PrePOSE)

Cardiovascular

The Global Paradise System Registry

Cancer and neoplasms

An Open-Label, Phase 1b study to evaluate safety, tolerability and preliminary activity of the CTPS1 inhibitor STP938 in adult subjects with high risk essential thrombocythaemia who are resistant to or intolerant of hydroxycarbamide therapy (STP938-301)

CORRELATE-UK: COnsistency of Response with RimegEpant oral Lyophilisate in Acute Treatment of migrainE in the United Kingdom (CORRELATE-UK)